J&J | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 9.61B 6.98B 2025-03
Abbott USD 8.7B 363M 2025-03
Amgen USD 6.78B 401M 2024-12
AstraZeneca USD 9.91B 2.94B 2025-03
Baxter International USD 3.19B 644M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Biogen USD 2.01B 13.3M 2024-12
Boston Scientific USD 3.74B 144M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
CONMED USD 305.3M 11.85M 2025-03
Cooper Companies USD 782.7M 37.3M 2025-01
Dexcom USD 924.6M 82.4M 2024-12
Edwards Lifesciences USD 1.02B 55.3M 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Globus Medical USD 597.02M 19.41M 2024-12
Hologic USD 792M 34M 2024-12
Indivior 200M 193M 2025-03
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
Intuitive Surgical USD 1.68B 3.3M 2025-03
J&J USD 8.26B 10.37B 2025-03
Medtronic USD 6.65B 162M 2025-01
Merck USD 9.66B 1.67B 2025-03
Merit Medical Systems USD 314.32M 4.28M 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
Stryker USD 5.86B 1.45B 2024-12
Tandem Diabetes Care USD 355.3M 72.07M 2025-03
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12
Zoetis USD 1.59B 71M 2024-12



J&J Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.